I missed before we had some MDs on Twitter discuss
Post# of 148310
(Total Views: 437)
Posted On: 05/16/2019 12:52:42 AM
I missed before we had some MDs on Twitter discussing the tnbc trial design, a few related threads but here are a couple.
https://www.twitter.com/ESchattner/status/112...7727511553
https://www.twitter.com/jesusanampa/status/11...1167973377
That second one was very sharp, he instantly got the significance of this trial.
https://www.twitter.com/ESchattner/status/112...7727511553
https://www.twitter.com/jesusanampa/status/11...1167973377
That second one was very sharp, he instantly got the significance of this trial.
Quote:
This trial most likely select patients CCR5+, or stratify according to this. So this trial would indeed, be generating a new biomarker for treatment.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼